Michael Tuen
Overview
Explore the profile of Michael Tuen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kister I, Curtin R, Piquet A, Borko T, Pei J, Banbury B, et al.
Ann Clin Transl Neurol
. 2024 May;
11(7):1750-1764.
PMID: 38713096
Objectives: (1) To plot the trajectory of humoral and cellular immune responses to the primary (two-dose) COVID-19 mRNA series and the third/booster dose in B-cell-depleted multiple sclerosis (MS) patients up...
2.
Ali N, Herati R, Mehta S, Leonard J, Miles J, Lonze B, et al.
Transpl Infect Dis
. 2023 Sep;
25(6):e14122.
PMID: 37707287
Background: Understanding immunogenicity and alloimmune risk following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in kidney transplant recipients is imperative to understanding the correlates of protection and to inform...
3.
Samanovic M, Oom A, Cornelius A, Gray-Gaillard S, Karmacharya T, Tuen M, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560562
Around the world, rollout of COVID-19 vaccines has been used as a strategy to end COVID-19-related restrictions and the pandemic. Several COVID-19 vaccine platforms have successfully protected against severe SARS-CoV-2...
4.
Samanovic M, Cornelius A, Gray-Gaillard S, Allen J, Karmacharya T, Wilson J, et al.
Sci Transl Med
. 2021 Dec;
14(631):eabi8961.
PMID: 34874183
The use of coronavirus disease 2019 (COVID-19) vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust...
5.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
Ann Rheum Dis
. 2021 May;
80(10):1339-1344.
PMID: 34035003
Objective: To investigate the humoral and cellular immune response to messenger RNA (mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at New...
6.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
medRxiv
. 2021 May;
PMID: 34013285
Objective: To investigate the humoral and cellular immune response to mRNA COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at NYU Langone Health...
7.
Samanovic M, Cornelius A, Gray-Gaillard S, Allen J, Karmacharya T, Wilson J, et al.
medRxiv
. 2021 Feb;
PMID: 33594383
The use of COVID-19 vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust humoral responses and...
8.
Hessell A, Li L, Malherbe D, Barnette P, Pandey S, Sutton W, et al.
J Immunol
. 2021 Feb;
206(6):1266-1283.
PMID: 33536254
The role of vaccine-induced anti-V2 Abs was tested in three protection experiments in rhesus macaques. In an experiment using immunogens similar to those in the RV144 vaccine trial (Anti-envelope [Env]),...
9.
Banin A, Tuen M, Bimela J, Tongo M, Zappile P, Khodadadi-Jamayran A, et al.
J Int AIDS Soc
. 2019 Jul;
22(7):e25362.
PMID: 31353798
Introduction: In Cameroon, a manifold diversity of HIV strains exists with CRF02_AG and unique recombinant forms (URFs) being the predominant strains. In recent years, a steady increase in URFs and...
10.
Tuen M, Bimela J, Banin A, Ding S, Harkins G, Weiss S, et al.
Front Immunol
. 2019 May;
10:1062.
PMID: 31139189
Genetic and immunologic analyses of epidemiologically-linked HIV transmission enable insights into the impact of immune responses on clinical outcomes. Human vaccine trials and animal studies of HIV-1 infection have suggested...